Lantus is insulin glargine, a long-acting basal insulin. If you’re looking for alternatives, here are common options, depending on your type of diabetes, country, and what you’re trying to achieve (cost, dosing schedule, risk of lows, etc.):
Long-acting insulins (basal)
- Basaglar (insulin glargine U-100) — a biosimilar to Lantus; similar effect and dosing, often cheaper.
- Semglee (insulin glargine biosimilar) — another glargine option in many markets.
- Toujeo (insulin glargine U-300) — same active drug (glargine) but more concentrated; slightly different duration and may have different injection volume/dosing.
- Levemir (insulin detemir) — another long-acting option; duration can be 12–24 hours and may require twice-daily dosing for some people.
- Tresiba (insulin degludec) — ultra-long-acting; very flexible dosing (often once daily, with a very stable basal level; sometimes allows more flexible timing).
- NPH insulin (Humulin N, Novolin N) — intermediate-acting option; less predictable and not as convenient as modern analogs, but still used in some settings.
Notes
- Lantus and Toujeo are both glargine but different formulations; units per mL and duration can differ.
- Availability and cost vary by country and insurance. Biosimilars (Basaglar, Semglee) can reduce cost.
- Switching between basal insulins usually requires a dose adjustment and physician guidance.
Non-insulin options (for type 2 or when insulin isn’t needed yet)
- GLP-1 receptor agonists (e.g., semaglutide, dulaglutide, liraglutide)
- SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin)
- DPP-4 inhibitors (sitagliptin, linagliptin)
- Metformin (often first-line)
- Sulfonylureas or meglitinides (glipizide, others)
These are not insulin and work differently; suitability depends on medical history and other factors.
If you’re considering a switch, talk with your clinician about:
- Which option best fits your blood sugar pattern, risk of hypoglycemia, and lifestyle.
- Dosing changes and how to monitor (start dose, titration, monitoring blood glucose).
- Insurance coverage and patient-assistance programs if cost is a concern.
Would you like guidance tailored to your location (country) and whether you’re using Lantus for type 1 or type 2 diabetes? If you have a specific goal (lower cost, easier dosing, fewer lows), I can help narrow the options.